SMi Source lesson Anticoagulation: Novel Oral Anticoagulants has the following microlearning topics
1. Introduction
2. Overview of Anticoagulant Agents
3. Limitations of Traditional Rapid Acting and Traditional Oral Anticoagulants
4. Development and Advantages of Novel Oral Anticoagulants (NOACs)
5. Complexities of Novel Oral Anticoagulants (NOACs)
6. Novel Oral Anticoagulants
7. Stroke Prevention in Atrial Fibrillation (AF)
8. Stroke Prevention in Atrial Fibrillation (AF): Guidelines
9. Venous Thromboembolism (VTE)
10. Administration of Novel Oral Anticoagulants: Overview
11. Dabigatran Overview
12. Indications
13. aPTT, Renal Impairment, Special Considerations and Mechanism of Action
14. Clinical Pharmacology
15. Clinical Pharmacology: Pharmacokinetics
16. Contraindications, Boxed Warning, and Precautions
17. Overview: Rivaroxaban
18. Indications, Dosage and Administration
19. Use in Patients with Renal Impairment
20. Clinical Pharmacology: Pharmacodynamics, Laboratory Monitoring and Anticoagulant Reversal
21. Pharmacokinetics: Absorption
22. Contraindications and Boxed Warning
23. Warnings, Precautions and Use in Pregnancy
24. Overview: Apixaban
25. Apixaban: Dosage and Administration
26. Apixaban: Mechanism of Action
27. Clinical Pharmacology: Pharmacodynamics and Anticoagulant Reversal
28. Pharmacokinetics: Absorption
29. Drug Interaction Studies
30. Apixaban: Contraindications and Boxed Warning
31. Apixaban: Warnings, Precautions and Use in Pregnancy
32. Summary of Agents
